Recently added

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Sharman, Jeff; Munir, Talha; Grosicki, Sebastian; Roeker, Lindsey; Burke, John; Chen, Christine I.; Bosch, Francesc (American Society of Clinical Oncology, 2025-08-01)

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Shitara, Kohei; Lorenzen, Sylvie; Li, Jin; Bai, Yuxian; González Fernández, Manuel; Aguilar, Mynor; Acosta Eyzaguirre, Daniel; Tabernero, Josep (American Society of Clinical Oncology, 2025-08-01)

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

Castet, Florian; Salcedo, Maria-Teresa; Nuciforo, Paolo; Aguilar, Susana; Vivancos, Ana (Taylor & Francis, 2025)

[Translated article] Multicenter, Prospective, Case–Control Study of Exposome in Melanoma

Navarro-Bielsa, Alba; Gracia-Cazaña, Tamara; Almagro Sánchez, Manuel; De-la-Fuente, Sonia; Flórez, Ángeles; Yélamos, Oriol; González-Cruz, Carlos (Elsevier, 2025-05)

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study

Papiol, Elisabeth; Berrueta, Julen; Manrique, Sara; CLAVERIAS CABRERA, LAURA; Ruiz-Rodriguez, Juan Carlos; Ferrer, Ricard (MDPI, 2025-06)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

[Translated article] Multicenter, Prospective, Case–Control Study of Exposome in Melanoma

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321) ﻿

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study ﻿

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide ﻿

[Translated article] Multicenter, Prospective, Case–Control Study of Exposome in Melanoma ﻿

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study ﻿

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

[Translated article] Multicenter, Prospective, Case–Control Study of Exposome in Melanoma

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study